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 Abstract  
Hypotension is a well-recognized phenomenon associated with any spinal anesthesia. It is most 
particularly evident in the parturients as a higher block is required for cesarean section (C-
section) (Nagelhout, 2014). These populations are also more prone to the effect of 
sympathectomy because of decreased sensitivity to endogenous vasoconstrictors in addition to 
increased synthesis of endothelium vasodilators (Miller, 2009). Sympathectomy results in 
hypotension and other adverse effects such as nausea and vomiting. Many studies over the 
decades have examined the best management option for the hypotension. This review seeks to 
determine the best management regimen for the use of the vasopressor phenylephrine. Eleven 
studies are used to examine the use of prophylactic intravenous (IV) phenylephrine infusion 
versus IV bolus regimen to manage the sympathectomy-induced hypotension associated with 
spinal anesthesia in parturients undergoing C-section. Nine out of the eleven had better 
hemodynamic outcomes with the use of infusion over bolus regimes. When the use of a weight-
based prophylactic IV phenylephrine infusion was compared to a non-weight based infusion, the 
intervention group was hemodynamically more stable compared to the control group whose 
weights were omitted in the dose. While there were incidences of reactive hypertension with the 
control group, there was no statistically significant adverse effect on the parturients and the fetus. 
These findings suggest that it is best for anesthesia providers to use a weight-based prophylactic 
IV phenylephrine infusion for the management of spinal-induced hypotension.  
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Prophylactic Phenylephrine Infusion Versus Bolus Regimens During Spinal Anesthesia for         
Cesarean Section 
                                                           Introduction 
Although the definition of hypotension may vary from one study to the other, according to 
Klohr, Roth, Hofmann, Rossaint, and Heesen (2010) approximately 80% of parturients 
undergoing cesarean section (C-section) under spinal anesthesia develop hypotension without 
adequate prophylaxis. For this paper, hypotension is defined as systolic blood pressure (SBP) 
less than 80% of baseline value. Severe hypotension can result in adverse effects that include 
nausea and vomiting, unpleasant feeling of impending doom and fetal acidosis (Kee, Khaw, Ng 
& Lee, 2004). Hypotension must be managed in a timely manner before cardiovascular collapse 
occurs. Treating the hypotension is not the only concern for the anesthesia provider, but choosing 
the right vasopressor regimen is essential to prevent unwanted adverse effects. Providers must be 
enlightened on this as studies have shown that significant variations exist in the regimen used in 
managing the hypotension associated with spinal anesthesia (Allen, Muir, George, & Habib, 
2009).  
 Over the years, the use of vasopressors in spinal associated hypotension has evolved. It 
took more than four decades to arrive at a conclusion that phenylephrine is the ideal vasopressor 
for the management of spinal-induced hypotension (Cooper, 2012). Whether to give a 
prophylactic intravenous (IV) phenylephrine infusion or an IV bolus immediately after 
intrathecal administration or to wait and initiate an infusion or give a bolus with the onset of 
hypotension remains uncertain. The paper presented here will give an overview of the 
physiological changes with pregnancy, spinal anesthesia with C-sections and its hemodynamic 
outcome as well as vasopressors available for management. Also, relevant studies on IV 
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phenylephrine infusion and IV phenylephrine bolus administration for managing the hypotension 
with spinal anesthesia will be analyzed. Based on the analysis of the literature, a policy 
recommendation will be developed to help improve patient outcome in anesthesia practice. 
Background 
Obstetrics anesthesia is a high-risk area of anesthetic practice. The physiological changes 
during pregnancy and the addition of a fetus or fetuses pose unique challenges to the care 
provider administering the anesthesia (Nagelhout, 2014). Currently, evidence-based guidelines 
and technologies are in place to guide consistent and safe anesthesia management of this 
population. However, anesthesia providers still have to face problems such as advanced maternal 
age, maternal obesity, and an increased complexity of medical problems, which may affect 
women during this period of time (Jadon, 2010). Another concern is the physiological changes 
that occur as a result of pregnancy.  
Physiological Changes with Pregnancy 
 Pregnancy affects different body systems. The physiological changes associated with it are 
due to the effect of changes in the maternal hormone balance, biochemical shifts related to larger 
metabolic demands of the fetus and the placenta, as well as mechanical forces from the gravid 
uterus (Rollins & Lucero, 2012). However, the changes to the cardiovascular system have 
important anesthetic implications, particularly if spinal anesthesia is administered (Nagelhout, 
2014). With cardiac changes, systemic vascular resistance decreases owing to increased 
progesterone, nitric oxide, and prostacyclin with a decreased response to norepinephrine and 
angiotensin causing renal artery and aortic dilatation. Cardiac output is increased, due to an 
increase in heart rate as well as the role of the renin-angiotensin system. Renin-angiotensin 
increases blood volume by stimulating angiotensin I to be converted to angiotensin II by 
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angiotensin-converting enzymes (ACE). Angiotensin II constricts blood vessels, increases 
antidiuretic hormone (ADH) and aldosterone causing an increase in blood pressure. With 
placental delivery, relief of aortocaval compression and contraction of the uterus causes a greater 
increase in blood volume as well (Hines & Marschall, 2008).    
 The position the parturients is in also affects hemodynamic status. Irrespective of the high 
blood volume, hypotension usually occurs in a supine position as the gravid uterus can compress 
the aorta and vena cava, decreasing cardiac preload and output. The aortoiliac artery 
compression by the gravid uterus further decreases uterine perfusion regardless of the maternal 
blood pressure (Rollins & Lucero, 2012). The addition of these natural physiological changes to 
the physiological effect of decreased sympathetic tone in spinal anesthesia can have a major 
impact on the cardiovascular system (Nagelhout, 2014).  
Spinal Anesthesia for C- Section 
 In most cases of C-section, spinal anesthesia is used unless there are contraindications. 
Some of the contraindications from the literature of why regional may not be used in the 
parturients include coagulopathy, maternal refusal, medical history such as spinal abnormality, 
the experience of the anesthesia provider, indication and urgency of the C-section, and maternal 
status (Schmidt & Auler, 2012; Yeoh & Li, 2013). Rollins and Lucero (2012) also identify 
infection at the needle insertion site, hypovolemic shock and increased intracranial pressure as 
other contraindications for neuraxial anesthesia. 
 One advantage of neuraxial anesthesia is that it allows for the birthing process to be more 
meaningful. Single dose spinal (commonly used for C-section) has a faster onset and is reliable 
in providing surgical anesthesia from the mid-thoracic level to the sacrum (Rollins & Lucero, 
2012). There is the advantage of a faster procedure and for the mother to be awake during 
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delivery to experience and participate in the birthing process as well as to interact and bond with 
the baby.  
 Another advantage to neuraxial anesthesia is low anesthetic exposure to the fetus, resulting 
in a higher Apgar score (Schmidt & Auler, 2012). As supported by the study done by Abdallah, 
Elzayyat, Abdelhaq, and Gado (2014) the Apgar score in one and five minutes were higher in 
newborns of parturients who received regional instead of general anesthesia. The authors 
attributed this to the effect of sedation that accompanies general anesthesia. Also, in the study 
done by Mancuso et al. (2010) to compare the effect of general and spinal anesthesia for elective 
C-section, umbilical cord artery pH, Apgar score, the need for assisted ventilation and fetal 
outcome was more favorable with spinal anesthesia compared to general anesthesia.  
 While there are benefits to spinal anesthesia, there are also some drawbacks. One of the 
most common complications in the parturients is post dural puncture headache (PDPH). The rate 
is as high as 30% (Jadon, 2010). PDPH usually occurs with the use of cutting needle tip designs 
although it can also occur with the use of thinner quincke-type spinal needles and pencil point 
needles. Not managing this complication can lead to subdural hematoma which may be of high 
morbidity and mortality. PDPH can be self-limiting; if not, the most common effective 
management is the use of an epidural blood patch, which is the definitive treatment with a 
success rate of 96-98% (Jadon, 2010).  
 In addition to the above, a common complication of spinal anesthesia is the hypotension 
it produces. The adverse effect of sympathetic blockage that usually accompanies spinal 
anesthesia does not only affect the mother but also the fetus due to uteroplacental hypoperfusion, 
which could lead to an acute fall in intervillous blood flow with the potential for fetal acidemia 
(Abdallah, et al., 2014). In fact, in the studies by Abdallah et al. (2014) regional anesthesia was 
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associated with a lower systolic and diastolic blood pressure in the parturients compared with 
general anesthesia as a result of the sympathetic block that it causes. 
Physiology of Spinal Anesthesia  
Spinal block involves administration of a local anesthetic. It’s usually an intrathecal 
injection of 10mg to 15mg of hyperbaric bupivacaine at lumbar four to five (L4 to L5) spinal 
segment for a block at the level of thoracic four (T4) vertebra (Nagelhout, 2014). This dose is the 
95% effective dose (ED95) of parturients undergoing C-section and provides approximately 90 
to 120 minutes of surgical anesthesia. Adjuncts such as fentanyl, sufentanil, and epinephrine may 
be added to improve the density of the block and preservative free morphine 0.10mg to 0.25mg 
can also be added to reduce postoperative (postop) pain up to 18 to 24 hours (Miller, 2009). 
Dermatomal block at T4 is often associated with extensive spread of anesthesia resulting in 
hypotension in the parturients, which if untreated can cause fetal compromise (Nagelhout, 2014).  
Different body systems are affected by spinal anesthesia. The central nervous system, the 
cardiovascular system, the respiratory system, and the gastrointestinal system are all 
physiologically affected. The effect of anesthesia is produced through the inhibition of nerve 
impulse conduction in the central nervous system. This occurs when the local anesthetic 
concentration exceeds the minimum blocking concentration of a nerve exposed to a drug. As the 
local anesthetic spreads from its site of injection, the concentration gradient decreases, and the 
most susceptible nerves get blocked, leaving some nerves unblocked. This explains why 
differential blocks occur with neuraxial anesthesia. With differential block, sympathetic fibers 
may be blocked by six to seven segments higher than somatic sensory fibers (Nagelhout, 2014). 
The unmyelinated sympathetic fibers are affected before the myelinated sensory and motor 
fibers. Overall, the effect of spinal anesthesia on the cardiovascular system primarily depends on 
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the overall degree of sympathetic blockage as well as the spread of the anesthetic and the level of 
central sympathetic inhibition (Miller, 2009). 
Sympathectomy has a major effect on cardiovascular collapse. As sympathetic nervous 
system blockage results in arterial vasodilation, decreased systemic vascular resistance, venous 
pooling, and a reduction in venous return (Miller, 2009). These physiological changes often lead 
to a redistribution of blood resulting in hypotension. At the level of T4 blockage, which is 
usually the requirement for C-section, cardiac accelerators (nerves of the sympathetic innervation 
of the heart) are anesthetized. An imbalance between the vagus fibers, resulting in decrease heart 
rate, baroreceptor reflexes, volume receptor reflexes, and decreases in central sympathetic 
outflow all contribute to the complex cardiovascular response to neuraxial anesthesia (Miller, 
2009; Nagelhout, 2014). The outcome is the loss of normal cardiovascular homeostatic reflexes 
and the ability to compensate for cardiovascular changes.  
The effects of hypotension affect both the mother and the fetus. Fetal adverse effects are 
decreased uteroplacental blood flow impairing fetal oxygenation with the risk of asphyxial stress 
and fetal acidosis. Decrease in maternal cardiac output, nausea and vomiting, dizziness and 
decreased consciousness are some of the parturient’s adverse effects. Maintaining the blood 
pressure within 80% of baseline is significant to prevent the unpleasant effects of nausea and 
vomiting as well as prevent fetal oxygen deprivation (Lee, Kee, & Gin, 2002). Prophylactic IV 
phenylephrine administration prevents these unwanted adverse effects.   
The Ideal Vasopressor  
Phenylephrine was used to manage the hypotension associated with spinal anesthesia 
beginning in the 1960’s. However, there were concerns about placental perfusion due to 
increased uterine vascular resistance with subsequently decreased uterine blood flow due to the 
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alpha effects of phenylephrine (Cooper, 2012). The use of ephedrine then became prevalent and 
the gold standard vasopressor of choice for the management of spinal-induced hypotension. This 
was based on observation in pregnant sheep, which revealed better preservation of uteroplacental 
blood flow with ephedrine. However, there was a change with the use of ephedrine back to 
phenylephrine due to newer studies revealing fetal acidosis with ephedrine (Copper, 2012). This 
transition started in 2002 when Lee et al. (2002) published a quantitative systematic review 
changing the traditional idea that ephedrine was superior to phenylephrine in the management of 
the hypotension associated with spinal anesthesia in term parturients undergoing elective C-
section. In their study, they found the groups that received phenylephrine delivered babies with a 
higher umbilical arterial pH compared to the group that received ephedrine.  
In addition, newer studies are indicating that ephedrine has a five-fold higher risk of fetal 
acidosis and is also more likely to cross the placenta. Crossing the placenta raises the level of 
lactate, glucose, and catecholamines in the fetal circulation (Butwick, Columb, & Carvalho, 
2014). Its slow onset of action due to its indirect mechanism of action also makes phenylephrine 
a better option. Moreover, physiologically, response to spinal anesthesia involves decreased 
systematic vascular resistance, increased heart rate, and cardiac output (Nagelhout, 2014). With 
these physiological changes, the use of ephedrine does not make sense because ephedrine affects 
both alpha and beta receptors. The pharmacodynamic response will be an increase in heart rate 
and cardiac output from the beta one effects with vasoconstriction from the alpha one effect 
(Miller, 2009; Nagelhout, 2014). However, the use of ephedrine should not be totally ruled out in 
this population, though its use needs to be judicious.  
Phenylephrine, on the other hand, is a synthetic sympathomimetic amine with direct 
activity for the alpha one adrenergic receptor. Alpha one receptors mediate smooth muscle 
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contraction and vasoconstriction, and it also has a non-hemodynamic function of salivation, 
gastrointestinal relaxation, sweating, gluconeogenesis, and glycogenolysis (Miller, 2009). 
Phenylephrine, with an alpha one receptor activity increases blood pressure by vasoconstriction 
as well as increasing peripheral vascular resistance (Miller, 2009; Nagelhout, 2014). Reflex 
bradycardia usually occurs secondary to baroreceptor stimulation. It has an immediate onset of 
action and lasts between five to twenty minutes. Given that, the hemodynamic changes of spinal 
anesthesia are caused by preganglionic sympathetic blockage, using a vasopressor that will 
maintain adrenergic activity seems appropriate (Cooper, 2012). The use of phenylephrine to 
manage the spinal-induced hypotension in the parturients is not the only important factor, but 
how it is used can have a significant effect, as it will be seen in the literature review.  
Literature Review 
To determine which vasopressor regime is more effective in managing the hemodynamics 
of this population, a literature search on the topic was conducted from 2000 to present using 
CINAHL and ProQuest databases. The reference lists of the retrieved studies were also 
examined. Eleven blinded randomized control trials (RCTs) and one analysis study were used for 
this review. The sample population was physical status (PS) one and two parturients with term 
pregnancy of a single fetus undergoing elective C-section under spinal anesthesia. The 
hypothesis was IV phenylephrine infusion would cause less hypotension in the parturients as 
compared to IV phenylephrine bolus regimen under spinal anesthesia with elective C-section. 
The primary outcome was hypotension. The secondary outcomes were nausea and vomiting, 
umbilical blood gas and Apgar score. Research that used these outcomes was used so 
comparisons and conclusions can easily be made.  
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Phenylephrine can be administered as a weight-based or a non-weight based prophylactic 
IV infusion or in intermittent, IV single boluses. The treatment can either be started immediately 
after the administration of the intrathecal, anticipating a decrease in blood pressure, or it can be 
administered once the parturient becomes symptomatic (Cooper, 2012). To understand the 
optimal management of hypotension in this population, different authors have conducted many 
studies. One of these studies was by Doherty, Ohashi, Downey, and Carvalho (2012). In this 
double blind RCT, 30 parturients received IV phenylephrine at a fixed infusion rate of 
120mcg/min immediately after intrathecal injection of local anesthetic. An additional bolus of 
120mcg of IV phenylephrine was given when SBP decreased 20% from baseline. The other 30 
patients in the control group received IV phenylephrine bolus of 120mcg each time the SBP 
dropped 20% from baseline. From the conclusion of this study, there were no clinical benefits to 
administering IV phenylephrine infusion versus IV bolus regimens for managing hypotension in 
the parturients with spinal anesthesia during C-section. 
 Although there were no clinical benefits to IV phenylephrine infusion in this study, the 
group that received the IV boluses had blood pressures closer to the baseline initially after the 
spinal (Doherty et al. 2012). The intervention groups showed a statistically significant decrease 
(p=0.007) in blood pressure in the first six minutes after intrathecal administration and as such, 
required a higher total dose of phenylephrine to maintain maternal blood pressure close to the 
baseline. There was no difference in the rate of nausea and vomiting, Apgar score and umbilical 
blood gases between the two groups. The question about this study is whether the results can be 
generalized, as the dose of phenylephrine used (120mcg) is higher than the dose commonly used 
in other centers. Also, on examining the sample characteristics, the average weight of the 
parturients in the bolus group was 74kg compared to the 78kg in the infusion group. Perhaps 
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parturients with the larger average weight used more phenylephrine compared to the group with 
the lower average weight.  
Kee et al. (2004) have done various studies on hypotension associated with spinal 
anesthesia in the parturients. One of those studies is a double blind RCT with 50 subjects to 
investigate prophylactic IV phenylephrine infusion versus therapeutic IV bolus regimens. In this 
study, the intervention group (the group that received phenylephrine infusion) showed a 
statistically significant decrease in the incidence of hypotension compared to the control group. 
Similar to the study by Doherty et al. (2012), larger doses of IV phenylephrine were used in the 
intervention group compared to the control group, and there was no statistically significant 
difference in Apgar scores and umbilical cord blood gases between the two groups. However, 
nausea and vomiting were not measured in this study, and the dose of IV phenylephrine used was 
100mcg/min. Kee et al. (2004) concluded by indicating that using 100mcg/min of IV 
phenylephrine infusion is a safe and effective method of preventing the hypotension associated 
with spinal anesthesia in this population. The study was conducted in 2004 and is not as current 
as the study by Doherty et al. (2012); however, it is highly relevant to this systematic review and 
has minimal limitations although the sample size could be questionable. They used 26 parturients 
in the intervention group and 24 in the control group.  
Doherty et al. (2012) and Kee et al. (2004) both use an estimated IV phenylephrine dose 
without considering specific characteristics of the parturients. From a different perspective, 
Siddik-Sayyid, Taha, Kanazi, and Aouad (2014) as well as Neves et al. (2010) took account of 
the weights of the parturients in dosing the IV phenylephrine in their studies. In the double blind 
RCT involving a total of 80 parturients conducted by Siddik-Sayyid et al. (2014) weight-based 
IV phenylephrine infusion rate and rescue boluses were assessed. The intervention group was 
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given prophylactic IV phenylephrine infusion at a starting rate of 0.75mcg/kg/min, and the 
control group received IV normal saline infusion at the same rate. Rescue IV boluses were 
administered in both groups when SBP fell 20% from the baseline. Hypotension was 20% in the 
intervention group compared to 90% in the control group. Nausea and vomiting were 10% in the 
intervention group compared to 44% in the control group. However, the difference between the 
neonatal outcomes between the two groups was not different. A limitation of this study was there 
was bias in maintaining SBP very close to the baseline in the intervention group and below the 
baseline in the control group. The authors did not specify the reason for the bias. Blinding 
physicians effectively were also questionable as indicated by the study (Siddik-Sayyid et al., 
2014).  
Similarly, Neves et al. (2010) conducted a double blind RCT involving 160 parturients 
divided into three equal groups. A weight-based IV phenylephrine infusion for the intervention 
group (group one) at a rate of 0.15mcg/kg/min was used after the injection of the spinal 
anesthetic. Group two received a bolus of 50mcg IV phenylephrine immediately after spinal 
administration, and group three received 50mcg of IV phenylephrine bolus whenever SBP or 
diastolic blood pressure (DBP) dropped by 20% from the baseline. Similarly, to the study by 
Siddik-Sayyid et al. (2014), hypotension was significantly seen in the group that did not receive 
any prophylactic IV phenylephrine, which was group three, affecting 85%, compared to 33% and 
17% in group two and group one respectively. Nausea and vomiting were statistically significant 
affecting 40% in group three, 15% in group two and 10% in group one. The differences in the 
Apgar score among the groups were not statistically significant (Neves et al., 2010).            
Using a parallel approach, Lee et al. (2016) compared three different weight-based IV 
phenylephrine boluses in a RCT involving 184 subjects. Group 1 (PHE 1) received 1mcg/kg, 
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group 1.5 (PHE 1.5) received 1.5mcg/kg and group 2 (PHE 2) received 2mcg/kg of IV 
phenylephrine immediately after the spinal block. The control group received two ml of 0.9% 
normal saline. Hypotension was significant in the control group, accounting for 72%. In the 
intervention group, hypotension was 69% in the PHE1 group, 37% in the PHE1.5 group and 46% 
in the PHE2 group. There were no significant differences in nausea and vomiting, umbilical cord 
blood gas, and Apgar scores among the group. The authors recommended phenylephrine bolus of 
1.5mcg/kg for controlling the hemodynamics changes associated with spinal anesthesia in this 
population. One limitation of this study is that it cannot be generalized because they used a low 
dose local anesthetic (7mg of bupivacaine with 15mcg of fentanyl) for the spinal block. The 
usual dose as indicated by Nagelhout (2014) is 10 to 15mg of bupivacaine. 
Equally, to Lee et al. (2016), Tanaka, Balki, Parkes, and Carvalho (2009) carried out a 
double blind RCT with 50 parturients to determine the ED95 of phenylephrine for the 
management of spinal-induced hypotension and nausea with C-section. The first parturient was 
administered 40mcg of IV phenylephrine, and the dose to subsequent parturients differed by 
10mcg increments or decrements. The recommendations of Tanaka et al. (2009) for the ED95 of 
IV phenylephrine were 122mcg to 159mcg to manage spinal induced-hypotension in parturient. 
There is, however, a question with the tool they used to measure the ED95. The tool may be 
inaccurate as there is a wide gap for the ED95, making it difficult to determine a precise, 
effective dose. This is a limitation of this study; therefore, the study cannot be generalized.  
Kee et al. (2004) took a different approach to conducting another RCT with 75 parturients 
divided into three groups to determine the optimal hemodynamic support during spinal 
anesthesia with C-section. In this study, IV phenylephrine 100mcg/min was infused for two 
minutes after intrathecal block. After the two minutes mark, depending on the parturients 
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randomly assigned group (maintain SBP at 100% baseline, at 90% baseline, or at 80% baseline), 
the phenylephrine infusion was either continued or stopped. The group with the 100% baseline 
presented with a low incidence of hypotension compared to the group with the 90% and 80% 
baseline. Umbilical pH was higher in the group with 100% baseline than in the group with 80%. 
Also, the group with 80% baseline had a higher incidence of nausea and vomiting, followed by 
the group with 90% baseline. These authors concluded by indicating that, for optimal 
management, phenylephrine needs to be titrated to maintain SBP near baseline in these 
populations.   
While Kee et al. (2004) used different percentages of baseline SBP to determine the 
optimal hemodynamic support, Allen, George, White, Muir, and Habib (2010) used four fixed 
rates of IV phenylephrine infusion regimens (25mcg/min, 50mcg/min, 75mcg/min and 
100mcg/min) in a double blind RCT with 100 parturients. The various groups received the 
applicable IV phenylephrine infusions rates and the control group received a placebo. The 
authors concluded by indicating that IV prophylactic phenylephrine infusion was effective in 
reducing the hypotensive episodes with spinal during C-section. Also, 25mcg/min and 
50mcg/min infusions provided greater maternal hemodynamic stability as there was a high 
incidence of hypertension in the 75mcg/min and 100mcg/min group. However, the difference in 
the incidence of nausea and vomiting, umbilical cord blood gas and Apgar score among the 
groups was not statistically significant. Two liters of crystalloids were co-administered with the 
IV phenylephrine infusion in this study. This makes the generalizability of the study questionable 
because different anesthesia providers may use various types of fluids (crystalloids versus 
colloids) at different times (before or after intrathecal injection). At such, the findings of the 
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study may be different if another type of fluid was administered and/or the time of administration 
was different.   
Stewart et al. (2010) as well as Ansari, Hashem, Hassan, Gamassy, and Saleh (2011) 
conducted RCTs studies involving 75 and 117 parturients respectively. Both studies initiated IV 
phenylephrine infusion immediately after spinal block at rates of 50mcg/min and 100mcg/min 
with the addition of boluses to maintain SBP at 80% of baseline. Both studies did not find 
significant difference in the incidence of hypotension, nausea, and vomiting as well as umbilical 
blood gas among the groups (Stewart et al., 2010; Ansari et al., 2011). The limitation of Stewart 
et al. (2010) study was that there was no control group to compare to the intervention group.    
In Cooper et al. (2006) prospective evaluation of phenylephrine for SBP control during 
spinal anesthesia, 100 parturient were used. One dose of IV phenylephrine infusion at 
67mcg/min was started after spinal administration and was titrated to keep SBP at 80% to the 
baseline. It was not indicated in the study as to why this dose was chosen. There were still 
episodes of hypotension and nausea in the study; they reported 15% and 13% respectively. There 
are, however, concerns with regards to the ethical review of the research. The authors indicated 
ethical review board was not needed since recording arterial blood pressure was a standard 
procedure, and there were to be no other interventions. 
 In the Mwaura, Mung’ayi, Kabugi, and Mir (2016) RCT, 108 parturient were recruited. 
This study did something different by giving the intervention group a weight-based IV 
phenylephrine infusion at 0.5mcg/kg/min immediately after spinal block while the control group 
received IV phenylephrine at a fixed infusion rate of 37.5mcg/min. The incidence of hypotension 
was statistically significantly low on the weight-adjusted dose group compared to the fixed dose 
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group (p=0.05). These authors recommended weight-based infusion regimen for management of 
spinal-induced hypotension.  
Discussion 
The studies presented in this paper used different approaches to determine which method 
of phenylephrine administration provided the best hemodynamic outcomes. From the review, 
prophylactic IV phenylephrine infusion had a better outcome in controlling the hemodynamics of 
parturients scheduled for C-section under spinal anesthesia. To prevent periodic hypertension 
with the IV prophylactic infusion, it is recommended for anesthesia providers to use a weight-
based phenylephrine infusion. Although there are slight differences in the study designs used, a 
major similarity is that they were all level one RCTs except for the study by Cooper et al. (2012), 
which was an analysis. Being a level one study makes it easier for comparison of the outcomes 
since they have control groups.  
Another similarity in the study designs was all the studies had very similar inclusion and 
exclusion criteria. The parturients in all of the studies were a PS one or two, carrying a term 
single fetus and where undergoing an elective C-section under spinal anesthesia. Patient refusal, 
contraindications to spinal anesthesia, allergy to phenylephrine, hypertension, cardiac or 
cerebrovascular disease, fetal abnormalities, and diabetes excluding gestational diabetes were the 
exclusion criteria used in the studies. However, some of the studies failed to indicate how old the 
parturients were. Older parturients may respond hemodynamically different under spinal 
anesthesia, compared to younger parturients. Bajwa, Kulshrestha, and Jindal (2013) identified 
the age 35 years and older as a risk factor for developing severe hypotension with spinal 
anesthesia in C-section. Future studies on this topic should include the age of the population used 
as it can have an impact on the results of the study.  
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One significant difference in the study designs that may have influenced the results was 
the use of fluid boluses. The majority of the studies indicated fluid boluses were administered; 
however, the authors do not specify whether the fluid was administered before the spinal or after 
the spinal. Also, some of the studies did not administer fluid boluses. They only used fluids to 
keep the vein open. Moreover, different studies used different type of fluids; some used 
crystalloids and others used colloids. Colloids are more effective in optimizing blood volume 
during spinal anesthesia due to their longer half-life (Bajwa et al., 2013). The different effects of 
the fluids in the intravascular compartment may have had an impact on the results of the studies. 
This makes the study hard to be generalized in this population since the timing and the type of 
fluid administered is unclear in some of the studies. Future studies need to be specific on the time 
and type of fluid administered as this is an important piece of hemodynamic stability and may 
have an impact on the outcome if the study was to be generalized.   
The outcomes of the studies used were the same. However, different studies used 
different factors as primary outcome. For example, the study by Kee et al. (2004) used fetal 
umbilical blood gas as their primary outcome while the study by Stewart et al. (2010) used 
hypotension as their primary outcome. This is a limitation of this review, as a more definite 
conclusion would have been drawn if the studies used all had the same primary outcome. Future 
analysis on this subject can try to review studies with exactly the same primary outcomes. 
However, it may not be a large review as there are a limited number of studies using the same 
primary outcome in this topic. 
Another limitation of the review is the studies used different doses of bupivacaine and 
some studies added adjuncts such as fentanyl and morphine to the spinal anesthetic. Most of the 
studies used 0.5% hyperbaric bupivacaine with doses ranging from 10mg to 13.5mg. There were 
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few studies that used 0.75% hyperbaric bupivacaine, 12mg to 12.75mg. Preservative free 
fentanyl 10mcg to 15mcg and preservative free morphine 100mcg to 150mcg were the adjuncts 
added. The different dose of spinal anesthetic will result in different hemodynamic outcomes 
with high spinal resulting in a more profound hypotension (Nagelhout, 2014). It would have been 
preferred to use studies with the same doses of spinal anesthetic so that the generalizability of the 
outcome can be certain. However, the probability of getting an adequate number of studies that 
are using the same dose of bupivacaine is very small. In fact, there were a limited number of 
primary studies on the topic. Being selective of the dose of spinal anesthetic would have made 
this review impossible. 
The policy recommendation derived from the analysis of the literature presented here is 
that anesthesia providers should use a weight-based prophylactic IV phenylephrine infusion to 
manage the hypotension associated with spinal anesthesia in the parturients undergoing C-
section. Prophylactic IV phenylephrine infusion prevents the profound hypotension and its 
associated unfavorable outcomes such as nausea and vomiting, feeling of impending doom, 
decreased umbilical pH and decreased Apgar score (Lee, Kee, & Gin, 2002). Adopting this 
practice will reduce these unwanted adverse effects and may improve patient satisfaction and 
outcome. As anesthesia providers aim to provide vigilant, safe, and competent care with 
minimum complications, they also ensure patients have a good experience in the process. 
Conclusion 
 The research presented here supports the use of prophylactic IV phenylephrine infusion 
to manage the sympathectomy-induced hypotension associated with spinal anesthesia in 
parturients undergoing C-section. Using a weight-based prophylactic IV phenylephrine infusion 
was superior in stabilizing hemodynamics in the parturients compared to a non-weight based IV 
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phenylephrine infusion. This is because there were incidences of reactive hypertension with the 
non-weight based prophylactic IV phenylephrine infusion, although there was no statistically 
significant adverse effect on the parturients and the newborns. Thus, it would be recommended 
to anesthesia providers to use a weight-based prophylactic IV phenylephrine infusion to manage 
the hypotension associated with spinal anesthesia in the parturients undergoing C-section. 
Providing optimal hemodynamic support in this population is important to prevent the unpleasant 
effects of nausea and vomiting as well as the adverse effects of cardiovascular instability, and 
most importantly, a decrease in fetal oxygenation. Adopting the recommendation from this 
literature analysis into practice may contribute to better patient outcome and satisfaction.  
This review’s findings can be generalized to the parturients population scheduled for C-
section under spinal anesthesia. However, factors such as dose of local anesthetic, adjuncts added 
to the local anesthetic, age, type and kind of fluid administration were not well defined in the 
studies, and may have an impact on the outcome if the studies were to be generalized. Future 
studies on the subject should be more specific and clear on those factors. There is a question of 
whether the hemodynamic outcome of the parturients would have been different if it were an 
emergency C-section. Future studies can explore more on phenylephrine regimes in emergency 
C-section under spinal anesthesia.  
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